Literature DB >> 20065793

Approach to optic neuropathies: clinical update.

Sashank Prasad1, Nicholas J Volpe, Laura J Balcer.   

Abstract

Visual loss is a common symptom brought to the attention of the practicing neurologist. In this circumstance, the proper identification of an optic neuropathy is critical. Recognition of key clinical clues will permit the clinician to construct a likely differential diagnosis and pursue appropriate testing. This review first addresses the elements of the history and examination which are most useful in evaluating a patient with visual loss, and then briefly discusses the main entities responsible for causing unilateral and bilateral optic neuropathies.

Entities:  

Mesh:

Year:  2010        PMID: 20065793     DOI: 10.1097/NRL.0b013e3181be6fad

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  5 in total

1.  Peripapillary vessel density in pediatric cases with buried optic disk drusen.

Authors:  Ibrahim Çağrı Türker; Ceylan Uslu Doğan; Saniye Üke Uzun; Dilek Güven
Journal:  Int Ophthalmol       Date:  2021-01-18       Impact factor: 2.031

2.  Approach to the patient with acute monocular visual loss.

Authors:  Sashank Prasad; Steven L Galetta
Journal:  Neurol Clin Pract       Date:  2012-03

3.  Multifocal visual evoked potential recordings in compressive optic neuropathy secondary to pituitary adenoma.

Authors:  Manju Jayaraman; S Ambika; Rashmin Anilkumar Gandhi; Shikha Rajesh Bassi; Priya Ravi; Parveen Sen
Journal:  Doc Ophthalmol       Date:  2010-09-04       Impact factor: 2.379

4.  Beware the Retrobulbar Optic Neuritis Diagnosis.

Authors:  Kealan McElhinney; Maedbh Rhatigan; Zornitsa Tsvetanova; Conor O'Keane; Patricia Logan
Journal:  Case Rep Ophthalmol       Date:  2022-06-10

5.  Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.

Authors:  Manju Jayaraman; Rashmin Anilkumar Gandhi; Priya Ravi; Parveen Sen
Journal:  Indian J Ophthalmol       Date:  2014-03       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.